The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants
Open accessAbstract
We examined the effectiveness and safety of the combination of rifampin plus ofloxacin given orally for treating prosthetic orthopedic implants infected with staphylococci. The prospective cohort study was conducted in a referral public hospital with ambulatory care services between 1985 and 1991. Consecutive patients from whom Staphylococcus organisms susceptible to the study drugs were isolated from their orthopedic implants and who had no contraindication to the treatment were eligible for the study. All patients were treated orally with rifampin, 900 mg/day, plus ofloxacin, 600 mg/day. Patients with hip prosthesis infection were treated for 6 months, with removal of any unstable prostheses after 5 months of treatment; patients with knee prosthesis infection were treated for 9 months, with removal of the prosthesis after 6 months of treatment; and patients with infected bone plates were treated for 6 months, with removal of the plate after 3 months of treatment, if necessary. Monthly clinical evaluations were conducted until the completion of the treatment and follow-up or telephone interviews were conducted at 6, 12, 24, 36, 48, and 60 months thereafter. Treatment failures were documented by clinical evaluation, sampling of the infected site for culture and antibiotic activity measurement, and fistulography, if possible. Cure was defined as the absence of clinical, biological, and radiological evidence of infection 6 months after the completion of treatment, treatment failure was defined as the absence of cure, and relapse was defined as the reappearance of infection caused by the same Staphylococcus isolate that caused the original infection, regardless of the timing of this secondary infection. Among 51 patients included in the study and evaluable for safety, 4 patients had side effects and were not evaluable for treatment effectiveness; the overall success rate was 74% among 47 patients, with a success rate of 81% for the hip prosthesis group, 69% for the knee prosthesis group, and 69% for the osteosynthesis device group. Eight treatment failures were relaxed to the isolation of a resistant bacterium. The combination of rifampin administered orally plus ofloxacin is a suitable alternative to the conventional long-term intravenous therapy for treatment of orthopedic implants infected with staphylococci.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial adherence to biomaterials and tissue. The significance of its role in clinical sepsis.
Gristina, A. G., & Costerton, J. W. (1985) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-198567020-00014 · Cited by 571
Two-stage reimplantation for the salvage of infected total knee arthroplasty.
Insall, J. N., Thompson, F. M., & Brause, B. D. (1983) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-198365080-00008 · Cited by 555
Deep wound sepsis following total hip arthroplasty
Fitzgerald, R., Nolan, D., Ilstrup, D., Van Scoy, R., Washington, J., & Coventry, M. (1977) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-197759070-00001 · Cited by 477
Widmer, A. F., Frei, R., Rajacic, Z., & Zimmerli, W. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.1.96 · Cited by 315
Salvati, E. A., Robinson, R. P., Zeno, S. M., Koslin, B. L., Brause, B. D., & Wilson, P. D. (1982) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-198264040-00007 · Cited by 290
Antimicrobial Treatment of Orthopedic Implant-related Infections with Rifampin Combinations
Widmer, A. F., Gaechter, A., Ochsner, P. E., & Zimmerli, W. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.6.1251 · Cited by 253
Clinical and microbial features of prosthetic joint infection
Inman, R. D., Gallegos, K. V., Brause, B. D., Redecha, P. B., & Christian, C. L. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90434-0 · Cited by 171
Chuard, C., Herrmann, M., Vaudaux, P., Waldvogel, F. A., & Lew, D. P. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.12.2611 · Cited by 143
Norden, C. W., & Shaffer, M. (1983) · The Journal of Infectious Diseases · doi:10.1093/infdis/147.2.352 · Cited by 114
New Quinolones in the Treatment of Joint and Bone Infections
Desplaces, N., & Acar, J. F. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.supplement_1.s179 · Cited by 77
Cited by
Zimmerli, W., Trampuz, A., & Ochsner, P. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmra040181 · Cited by 3,116
Osmon, D. R., Berbari, E. F., Berendt, A. R., Lew, D., Zimmerli, W., Steckelberg, J. M., Rao, N., Hanssen, A., & Wilson, W. R. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis803 · Cited by 2,266
Tande, A. J., & Patel, R. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00111-13 · Cited by 1,885
Lew, D. P., & Waldvogel, F. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16727-5 · Cited by 1,883
Zimmerli, W. (1998) · JAMA · doi:10.1001/jama.279.19.1537 · Cited by 1,079
Lew, D. P., & Waldvogel, F. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361406 · Cited by 617
Infection after total hip arthroplasty. Past, present, and future.
Garvin, K. L., & Hanssen, A. D. (1995) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199510000-00015 · Cited by 497
Outcome of Prosthetic Joint Infections Treated with Debridement and Retention of Components
Marculescu, C. E., Berbari, E. F., Hanssen, A. D., Steckelberg, J. M., Harmsen, S. W., Mandrekar, J. N., & Osmon, D. R. (2006) · Clinical Infectious Diseases · doi:10.1086/499234 · Cited by 482
Systemic Antibiotic Therapy for Chronic Osteomyelitis in Adults
Spellberg, B., & Lipsky, B. A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir842 · Cited by 470
Bacterial and Fungal Biofilm Infections
Lynch, A. S., & Robertson, G. T. (2008) · Annual Review of Medicine · doi:10.1146/annurev.med.59.110106.132000 · Cited by 447
Prosthetic joint infections: update in diagnosis and treatment
Trampuz, A., & Zimmerli, W. (2005) · Swiss Medical Weekly · doi:10.4414/smw.2005.10934 · Cited by 424
Byren, I., Bejon, P., Atkins, B. L., Angus, B., Masters, S., McLardy-Smith, P., Gundle, R., & Berendt, A. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp107 · Cited by 407
New Developments in Diagnosis and Treatment of Infection in Orthopedic Implants
Widmer, A. F. (2001) · Clinical Infectious Diseases · doi:10.1086/321863 · Cited by 407
Comparative Pharmacokinetics and Pharmacodynamics of the Rifamycin Antibacterials
Burman, W. J., Gallicano, K., & Peloquin, C. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140050-00002 · Cited by 337
DIAGNOSIS AND MANAGEMENT OF INFECTION AFTER TOTAL KNEE ARTHROPLASTY
TSUKAYAMA, D. T., GOLDBERG, V. M., & KYLE, R. (2003) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200300001-00014 · Cited by 333
Saginur, R., StDenis, M., Ferris, W., Aaron, S. D., Chan, F., Lee, C., & Ramotar, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.55-61.2006 · Cited by 332
Senneville, E., Melliez, H., Beltrand, E., Legout, L., Valette, M., Cazaubie, M., Cordonnier, M., Caillaux, M., Yazdanpanah, Y., & Mouton, Y. (2006) · Clinical Infectious Diseases · doi:10.1086/498112 · Cited by 320
Antibiotic treatment of Gram-positive bone and joint infections
Darley, E. S. R. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh191 · Cited by 266
Diagnosis and Management of Osteomyelitis: Decision Analytic and Pharmacoeconomic Considerations
Tavakoli, M., Davey, P., Clift, B. A., & Davies, H. T. (1999) · PharmacoEconomics · doi:10.2165/00019053-199916060-00003 · Cited by 256
Senneville, E., Joulie, D., Legout, L., Valette, M., Dezeque, H., Beltrand, E., Rosele, B., d'Escrivan, T., Loiez, C., Caillaux, M., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir402 · Cited by 255
Synergie et antagonisme en antibiothérapie
Denes, É., & Hidri, N. (2009) · Antibiotiques · doi:10.1016/j.antib.2009.02.001 · Cited by 12
Metadata
- Authors
- Drancourt, M., Stein, A., Argenson, J. N., Zannier, A., Curvale, G., & Raoult, D.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1993-06
- Volume
- 37
- Issue
- 6
- Pages
- 1214-1218
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2088923091
- Cited by
- 252
- References
- 14
- FWCI
- 6.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.